Arrowhead Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ARWR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Dec 24	SellUS$567,486	Christopher Anzalone	Individual	26,712	US$22.12
18 Apr 24	BuyUS$62,176	Hongbo Lu	Individual	2,400	US$28.00
01 Apr 24	SellUS$168,180	James Hamilton	Individual	6,000	US$28.03
20 Mar 24	BuyUS$82,990	Hongbo Lu	Individual	3,000	US$28.00
06 Mar 24	SellUS$1,407,600	Kenneth Myszkowski	Individual	40,000	US$35.19

Insider Trading Volume

Insider Buying: ARWR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARWR?
Owner Type	Number of Shares	Ownership Percentage
State or Government	31,615	0.0254%
Individual Insiders	4,891,583	3.93%
Hedge Funds	8,888,888	7.14%
General Public	21,607,431	17.4%
Institutions	89,014,925	71.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.8%.

Top Shareholders

Top 25 shareholders own 67.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.7%	BlackRock, Inc.	15,835,912	US$310.9m	0.97%	no data
9.83%	The Vanguard Group, Inc.	12,229,055	US$240.1m	0.12%	no data
7.14%	Avoro Capital Advisors LLC	8,888,888	US$174.5m	0%	2.44%
5.11%	State Street Global Advisors, Inc.	6,354,331	US$124.7m	8.85%	no data
4.88%	FMR LLC	6,067,062	US$119.1m	-10.9%	0.01%
3.93%	Slate Path Capital LP	4,885,000	US$95.9m	18%	1.54%
2.99%	Christopher Anzalone	3,715,048	US$72.9m	0%	no data
2.93%	T. Rowe Price Group, Inc.	3,651,071	US$71.7m	38.6%	0.01%
2.38%	Geode Capital Management, LLC	2,964,119	US$58.2m	0.89%	no data
2.09%	UBS Asset Management AG	2,595,761	US$51.0m	-1.62%	no data
1.98%	Artal Group S.A.	2,458,778	US$48.3m	-22.9%	1.44%
1.49%	JP Morgan Asset Management	1,848,679	US$36.3m	-0.45%	no data
1.27%	Norges Bank Investment Management	1,585,320	US$31.1m	0%	no data
1.15%	Morgan Stanley, Investment Banking and Brokerage Investments	1,432,016	US$28.1m	-12.2%	no data
1.07%	Northern Trust Global Investments	1,332,765	US$26.2m	0.76%	no data
0.95%	Goldman Sachs Group, Investment Banking and Securities Investments	1,178,564	US$23.1m	4.95%	0.01%
0.95%	Citadel Advisors LLC	1,177,577	US$23.1m	24.2%	0.03%
0.81%	Charles Schwab Investment Management, Inc.	1,006,935	US$19.8m	1.26%	no data
0.7%	Woodline Partners LP	865,794	US$17.0m	5.39%	0.15%
0.69%	BNY Asset Management	858,222	US$16.8m	-20.3%	no data
0.66%	Western Financial Corporation	820,239	US$16.1m	0%	8.69%
0.64%	Aquilo Capital Management, LLC	795,813	US$15.6m	-12.4%	23.09%
0.52%	Millennium Management LLC	645,604	US$12.7m	22%	0.01%
0.37%	Jane Street Group, LLC, Asset Management Arm	463,880	US$9.1m	-33.4%	0.01%
0.33%	Bank of America Corporation, Asset Management Arm	409,297	US$8.0m	13.1%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 21:42
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arrowhead Pharmaceuticals, Inc. is covered by 29 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ishan Majumdar	Baptista Research
Ying Huang	Barclays
Jason Matthew Gerberry	BofA Global Research